Exchange Surveillance
No active ASM or GSM measures on this stock.
Price band ± 5% · narrower than the standard 20%
Price
Trading Data
range barsReturns
absolute and vs benchmark indexAbout the Company
Natural Capsules Limited is a Public Limited Company established in the year 1993 at Bangalore and in the year 2003 at Pondicherry. Natural Capsules Limited is a well-equipped modern manufacturing plant to manufacture Hard Gelatin Capsule shells, Hard Cellulose Capsule shells and Pharmaceutical Dosage Forms in Capsule Dosage Form.The Company meets the statutory requirements as laid down by the authorities in respect to cGMP and cGLP practices. Since its inception, Natural Capsules has ensured to provide turnkey solutions to all its customers.The company also in the business segment of Capsules, Formulation.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- HQ
- Bengaluru (Bangalore), Karnataka
- Chairman
- C P Rangachar
- CEO & MD
- Sunil Laxminarayan Mundra
- Registrar
- Cameo Corporate Services Ltd.
- Exchange
- NSE
- ISIN
- INE936B01015
Institutional Demand
passive ownership through ETFsContext
where this company sitsFrequently Asked
▶What is the share price of Natural Capsules Ltd today?
Natural Capsules Ltd (NATCAPSUQ) is trading at ₹142.82. The price shown is the latest available from the exchange feed and updates through the trading session.
▶What is NATCAPSUQ’s P/E ratio versus the sector?
NATCAPSUQ trades at a P/E of 14.1. Its industry median is shown alongside it in Key Stats, so you can see at a glance whether the stock is priced above or below the businesses it competes with. A lower P/E is not automatically cheaper — it can also reflect slower expected growth.
▶What is NATCAPSUQ’s dividend yield?
NATCAPSUQ has a dividend yield of 0.00%, based on dividends declared over the last twelve months against the current price. The full dividend history is on the News & Filings tab.
▶What is NATCAPSUQ’s 52-week high and low?
NATCAPSUQ has traded between ₹136.36 and ₹234 over the past year. The Trading Data block shows where the current price sits inside that band.
▶What is the market capitalisation of Natural Capsules Ltd?
Natural Capsules Ltd has a market capitalisation of ₹180 crore.
▶What is NATCAPSUQ’s return on equity?
NATCAPSUQ reports a return on equity of 6.5%. ROE measures profit generated per rupee of shareholder capital, and is most meaningful compared against others in Drug Manufacturers - Specialty & Generic.
▶Who are NATCAPSUQ’s competitors?
The Peers block on this page lists other Drug Manufacturers - Specialty & Generic companies with their price, P/E and market capitalisation. The Valuation tab compares multiples against the industry median in more depth.
▶What is NATCAPSUQ’s promoter holding?
Promoters hold 50.92% of NATCAPSUQ. The Ownership tab shows the full shareholding pattern — promoter, FII, DII and public — and how each has moved across recent quarters.
▶Which indices include NATCAPSUQ?
Index membership is listed in the Context block on this page, along with the weight NATCAPSUQ carries in each. That weight is what determines how much passive money tracks the stock.
▶Is Natural Capsules Ltd a good buy?
We do not publish buy or sell calls. What this page gives you instead is the evidence: our Value & Investment Index for where the price sits against its own history, the Fundamental Strength Index for the quality of the business, an investment checklist of criteria applied to every stock, and pros and cons generated from NATCAPSUQ’s own numbers. The judgement is yours.
NATCAPSUQ at a glance
Natural Capsules Ltd operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector. Natural Capsules Ltd (NATCAPSUQ) last traded at ₹142.82, giving it a market capitalisation of ₹180 crore. The 52-week range is ₹136.36 to ₹234, and the price is 7% of the way up that range. It trades at a price-to-earnings ratio of 14.1. Promoters hold 50.92% of the company in the latest shareholding filing.
| Market cap | ₹180 crore |
|---|---|
| P/E | 14.1 |
| ROE | 6.5% |
| ROCE | 9.2% |